In The News

Shine Newshost2022-10-06T13:33:43-05:00

SHINE Technologies Names Ben Pratt as Chief People Officer

SHINE Technologies Names Ben Pratt as Chief People Officer

Eric Schmoldt2022-11-15T11:40:32-06:00November 15, 2022|

SHINE Honored by Goldman Sachs as Leading Innovator

SHINE Honored by Goldman Sachs as Leading Innovator

Eric Schmoldt2022-11-02T09:48:05-05:00November 1, 2022|

SHINE Gets Dutch Approval for Project to Improve Patient Access to Promising New Nuclear Medicine

SHINE Gets Dutch Approval for Project to Improve Patient Access to Promising New Nuclear Medicine

Eric Schmoldt2022-10-26T17:40:10-05:00October 17, 2022|

2022

SHINE Supercell Completes Testing Ahead of Shipment to U.S.

October 12, 2022|SAFER, HEALTHIER, CLEANER, News, Nuclear Medicine, 2022, News Releases|

Radiopharm Theranostics and SHINE Announce Agreement for Cancer-Fighting Isotope

September 20, 2022|SAFER, HEALTHIER, News, 2022, News Releases|

Phoenix Names Tom D’Orazio CEO

August 16, 2022|News, 2022, News Releases|

SHINE Submits Drug Master File for n.c.a. Lu-177

July 29, 2022|News, 2022, News Releases|

SHINE CEO to Deliver Keynote at Wisconsin Entrepreneurs’ Conference

May 26, 2022|News, 2022, News Releases|

SHINE Announces Chris Vessell as General Manager of Therapeutics Division

May 23, 2022|News, Therapeutics, 2022, News Releases|

SHINE and U.S. Department of Homeland Security Expand Contraband Detection

April 20, 2022|News, 2022, News Releases|

SHINE Appoints Financial and Energy Industry Veterans to Board of Directors

April 14, 2022|News, 2022, News Releases|

SHINE Founder, CEO Attending White House Summit on Fusion Energy

March 16, 2022|News, 2022, News Releases|

SHINE Technologies and ImaginAb Announce Lutetium-177 Clinical Supply Agreement

March 9, 2022|News, Therapeutics, 2022, News Releases|

2021

SHINE’s new name highlights technology competencies and multiple phase opportunities

September 22, 2021|News, 2021, News Releases|

SHINE commemorates completion of new corporate headquarters

August 6, 2021|News, 2021, General, News Releases|

SHINE Medical Technologies Closes $150-million Series C-5 Financing

June 28, 2021|News, 2021, News Releases|

SHINE Medical announces agreement with MURR

June 8, 2021|SAFER, News, Therapeutics, 2021, News Releases, Medical Isotopes|

SHINE, EDH enter distribution agreement for SHINE’s non-carrier-added Lu-177

May 25, 2021|HEALTHIER, News, Therapeutics, 2021, News Releases, Medical Isotopes|

SHINE selects Netherlands for European isotope production facility

May 19, 2021|News, 2021, Medical Isotopes|

SHINE, Phoenix merger focused on advancing fusion technology

April 20, 2021|News, 2021, News Releases, Nuclear Fusion|

SHINE appoints ESG, marketing experts to board.

March 18, 2021|News, 2021, News Releases|

SHINE announces weathertight production facility

March 25, 2021|News, 2021, News Releases|

2020

SHINE breaks ground on HQ and Therapeutics production facility

December 16, 2020|SAFER, HEALTHIER, CLEANER, News, Therapeutics, 2020, News Releases|

Von Gahlen building supercell for SHINE

November 23, 2020|News, 2020, News Releases, Medical Isotopes|

SHINE announces first sales of n.c.a. Lu-177

November 4, 2020|HEALTHIER, News, Therapeutics, 2020, News Releases, Medical Isotopes|

SHINE Receives Diversity Award

November 2, 2020|News, 2020, News Releases|

SHINE closes $80-million

September 3, 2020|News, 2020, News Releases|

NRC issues review schedule for SHINE application

May 11, 2020|News, 2020, News Releases|

SHINE & IOCB deliver Lu-177 doses to GE

January 21, 2020|HEALTHIER, News, Therapeutics, 2020, News Releases, Medical Isotopes|

Deploying nuclear fusion technology as part of our pursuit of an innovative, deliberate pathway to clean, abundant energy production

Headquarters

3400 Innovation Ct.
Janesville, WI 53546

info@shinefusion.com

Technology

Products

News and Resources

Company

SHINE Europe

© SHINE Technologies, LLC | All Rights Reserved

Privacy Policy | Terms and Conditions | Personal Data Access

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Advertisement

Others